Transfusion Medicine Reviews
Volume 20, Issue 1 , Pages 63-74 , January 2006

Proteomics: Applications Relevant to Transfusion Medicine

References 

  1. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429:464–468
  2. Marko-Varga G, Fehniger TE. Proteomics and disease—the challenges for technology and discovery. J. Proteome Res. 2004;3:167–178
  3. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 2002;1:845–867
  4. Zhou M, Lucas DA, Chan KC, et al. An investigation into the human serum “interactome”. Electrophoresis. 2004;25:1289–1298
  5. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975;250:4007–4021
  6. Tonge R, Shaw J, Middleton B, et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 2001;1:377–396
  7. Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology. Blood. 2004;103:3624–3634
  8. Pieper R, Gatlin CL, Makusky AJ, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics. 2003;3:1345–1364
  9. Rees-Unwin KS, Morgan GJ, Davies FE. Proteomics and the haematologist. Clin. Lab. Haematol. 2004;26:77–86
  10. Pieper R, Su Q, Gatlin CL, et al. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics. 2003;3:422–432
  11. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001;19:242–247
  12. Fenyo D. Identifying the proteome: software tools. Curr. Opin. Biotechnol. 2000;11:391–395
  13. Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999;17:994–999
  14. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature. 1989;340:245–246
  15. McQuibban GA, Gong JH, Tam EM, et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 2000;289:1202–1206
  16. Gygi SP, Rochon Y, Franza BR, et al. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999;19:1720–1730
  17. Ng JH, Ilag LL. Biochips beyond DNA: technologies and applications. Biotechnol. Annu. Rev. 2003;9:1–149
  18. Lesaicherre ML, Uttamchandani M, Chen GY, et al. Antibody-based fluorescence detection of kinase activity on a peptide array. Bioorg. Med. Chem. Lett. 2002;12:2085–2088
  19. Neuman de Vegvar HE, Robinson WH. Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics. Clin. Immunol. 2004;111:196–201
  20. Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 2002;20:359–365
  21. Adam GC, Sorensen EJ, Cravatt BF. Chemical strategies for functional proteomics. Mol. Cell. Proteomics. 2002;1:781–790
  22. Greenbaum DC, Baruch A, Grainger M, et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science. 2002;298:2002–2006
  23. Speers AE, Cravatt BF. Chemical strategies for activity-based proteomics. Chembiochem. 2004;5:41–47
  24. Chamrad DC, Korting G, Stuhler K, et al. Evaluation of algorithms for protein identification from sequence databases using mass spectrometry data. Proteomics. 2004;4:619–628
  25. Molloy MP, Brzezinski EE, Hang J, et al. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics. 2003;3:1912–1919
  26. Peri S, Navarro JD, Amanchy R, et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 2003;13:2363–2371
  27. Ge H, Walhout AJ, Vidal M. Integrating ‘omic’ information: a bridge between genomics and systems biology. Trends Genet. 2003;19:551–560
  28. Ideker T, Galitski T, Hood L. A new approach to decoding life: Systems biology. Annu. Rev. Genomics Hum. Genet. 2001;2:343–372
  29. Castrillo JI, Oliver SG. Yeast as a touchstone in post-genomic research: strategies for integrative analysis in functional genomics. J. Biochem. Mol. Biol. 2004;37:93–106
  30. Petricoin E, Wulfkuhle J, Espina V, et al. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J. Proteome Res. 2004;3:209–217
  31. Wolberg AS, Kon RH, Monroe DM, et al. Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am. J. Hematol. 2000;65:30–34
  32. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus. Med. Rev. 1997;11:130–144
  33. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics. 2002;2:288–305
  34. Garcia A, Prabhakar S, Brock CJ, et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2004;4:656–668
  35. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096–2104

 The first two authors contributed equally to this work.

PII: S0887-7963(05)00083-0

doi: 10.1016/j.tmrv.2005.08.006

Transfusion Medicine Reviews
Volume 20, Issue 1 , Pages 63-74 , January 2006

Article Tools

* Image Usage & Resolution